# PDL BioPharma, Inc. (PDLI) Source: https://www.quantisnow.com/company/PDLI Generated: 2026-11-10T07:28:10.053Z - Ticker: PDLI - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Biological Products (No Diagnostic Substances) - IPO year: 1992 ## Latest PDLI news and filings - 2025-04-16 12:00 UTC [Engine Capital Nominates Two Highly Qualified and Independent Candidates for Election to Lyft's Board of Directors at the 2025 Annual Meeting](https://www.quantisnow.com/insight/engine-capital-nominates-two-highly-qualified-and-independent-candidates-for-5989474) - 2024-04-18 12:00 UTC [Leadership Update] [BiomX Announces the Appointment of Susan Blum to its Board of Directors](https://www.quantisnow.com/insight/biomx-announces-the-appointment-of-susan-blum-to-its-board-5417442) - 2022-01-04 13:00 UTC [Leadership Update] [Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer](https://www.quantisnow.com/insight/apexigen-announces-appointment-of-francis-sarena-as-chief-operating-officer-2206314) - 2021-02-19 22:13 UTC [SEC Form SC TO-I/A filed](https://www.quantisnow.com/insight/sec-form-sc-to-ia-filed-415719) - 2021-02-12 20:20 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-390246) - 2021-02-11 21:22 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-385156) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351158) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351143) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351135) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351128) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351127) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351121) - 2021-02-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-351118) - 2021-02-03 22:57 UTC [SEC Form 4] [SEC Form 4: L.P. Capital Point Silver bought $383,475 worth of Common Stock (187,061 units at $2.05)](https://www.quantisnow.com/insight/sec-form-4-lp-capital-point-silver-bought-383475-worth-349786) - 2021-02-02 21:20 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343078) - 2021-02-02 21:20 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343075) - 2021-02-02 21:19 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343064) - 2021-02-02 21:18 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343059) - 2021-02-02 21:17 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343048) - 2021-02-02 21:16 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343034) - 2021-02-02 21:16 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-343027) - 2021-02-02 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-338625) - 2021-02-02 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-338616) - 2021-02-01 21:04 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-336678) - 2021-02-01 21:03 UTC [SEC Form POS AM filed](https://www.quantisnow.com/insight/sec-form-pos-am-filed-336669) - 2021-01-15 22:23 UTC [SEC Form SC TO-I filed](https://www.quantisnow.com/insight/sec-form-sc-to-i-filed-289614) - 2021-01-11 22:27 UTC [SEC Form SC 13D filed](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-274541) - 2021-01-11 21:32 UTC [SEC Form 3: Llc Management Asset West Park claimed ownership of 14,397,212 units of Common stock](https://www.quantisnow.com/insight/sec-form-3-llc-management-asset-west-park-claimed-ownership-274191) - 2021-01-11 21:30 UTC [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-274174) - 2021-01-08 21:53 UTC [SEC Form 15-12G filed](https://www.quantisnow.com/insight/sec-form-15-12g-filed-270025) - 2021-01-04 22:10 UTC [SEC Form 4: L.P. Capital Point Silver bought $15,813,032 worth of Common Stock (6,325,213 units at $2.50)](https://www.quantisnow.com/insight/sec-form-4-lp-capital-point-silver-bought-15813032-worth-251831) - 2020-12-31 23:48 UTC [SEC Form 4 Filed - GRYSKA DAVID W disposed of 20000 shares in 1 transactions](https://www.quantisnow.com/insight/sec-form-4-filed---gryska-david-w-disposed-of-248002) - 2020-12-29 21:56 UTC [Silver Point Capital L.P. acquired 631600 shares in 3 transactions](https://www.quantisnow.com/insight/silver-point-capital-lp-acquired-631600-shares-in-3-transactions-243463) - 2020-12-28 21:14 UTC [SEC Form 2 filed](https://www.quantisnow.com/insight/sec-form-2-filed-240792) - 2020-12-23 22:50 UTC [Silver Point Capital L.P. acquired 1565000 shares in 3 transactions](https://www.quantisnow.com/insight/silver-point-capital-lp-acquired-1565000-shares-in-3-transactions-238009) - 2020-12-23 00:51 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-235082) - 2020-12-14 13:30 UTC [PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat](https://www.quantisnow.com/insight/pdl-biopharma-enters-into-514-million-capital-provision-agreement-with-213868) - 2020-12-11 13:00 UTC [Leadership Update] [Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors](https://www.quantisnow.com/insight/alpine-immune-sciences-appoints-natasha-hernday-to-board-of-directors-211689) - 2020-12-08 21:05 UTC [PDL Announces Timeline for Voluntarily Delisting from Nasdaq](https://www.quantisnow.com/insight/pdl-announces-timeline-for-voluntarily-delisting-from-nasdaq-204949) - 2020-11-11 20:05 UTC [PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution](https://www.quantisnow.com/insight/pdl-biopharma-reports-2020-third-quarter-financial-results-and-sets-152105) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PDLI - Earnings history: https://www.quantisnow.com/earnings/PDLI - Dividend history: https://www.quantisnow.com/dividends/PDLI - Insider transactions: https://www.quantisnow.com/insiders/PDLI - Options chain: https://www.quantisnow.com/options/PDLI - SEC 8-K filings only: https://www.quantisnow.com/company/PDLI/8-k - RSS and alerts for PDLI: https://www.quantisnow.com/docs/rss-feeds.md